Clinical Trial Update: Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis [Phase 1]

View source ↗

Summary

Phase 1 safety study of a meningococcal polysaccharide diphtheria toxoid conjugate vaccine covering serogroups A, C, Y and W-135 has completed, per sponsor JN-I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections
• Meningococcal Meningitis

Drugs mentioned

• Meningococcal polysaccharide diphtheria toxoid conjugate vaccine (serogroups A, C, Y, W-135) (Meningococcal polysaccharide diphtheria toxoid conjugate vaccine)

Snippet

Sponsor: JN-International Medical Corporation | Conditions: Meningococcal Meningitis, Meningococcal Infections | Phase 1 | Status: COMPLETED